Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$411K Buy
32,078
+1,500
+5% +$17K 0.01% 814
2026
Q2
$275K Sell
30,578
-1,711
-5% -$15.7K 0.01% 1036
2026
Q1
$300K Buy
32,289
+942
+3% +$9.27K 0.01% 846
2025
Q4
$219K Buy
31,347
+7,982
+34% +$50.2K 0.01% 971
2025
Q3
$133K Buy
23,365
+393
+2% +$2.1K 0.01% 1267
2025
Q2
$110K Buy
22,972
+20,818
+966% +$119K 0.01% 1373
2025
Q1
$18.7K Buy
2,154
+1,765
+454% +$18.5K ﹤0.01% 2421
2024
Q4
$4.72K Sell
389
-991
-72% -$13.9K ﹤0.01% 2938
2024
Q3
$23.2K Buy
1,380
+606
+78% +$9.97K ﹤0.01% 2023
2024
Q2
$12.1K Buy
774
+124
+19% +$1.72K ﹤0.01% 2141
2024
Q1
$10.3K Buy
650
+189
+41% +$3.16K ﹤0.01% 2057
2023
Q4
$7.15K Buy
+461
New +$7.8K ﹤0.01% 2068

Other funds holding NEOG

GAMMA Investing's NEOG Position: Q3 2026 in Review

GAMMA Investing increased its Neogen (NEOG) stake by 4.9% in Q3 2026, buying an estimated $17K and bringing the position to 32,078 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #814.

GAMMA Investing first reported a position in NEOG in Q4 2023 and has held it in 12 quarters since. 10 funds tracked by Wall St. Rank hold NEOG as of Q3 2026.

  • GAMMA Investing held 32,078 shares of Neogen worth $411K as of Q3 2026.
  • GAMMA Investing bought 1,500 Neogen shares in Q3 2026, an estimated $17K.
  • Neogen made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #814 holding.
  • GAMMA Investing first reported a position in Neogen in Q4 2023 and has held it in 12 quarters since.
  • 10 funds tracked by Wall St. Rank held Neogen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.